Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mattijssen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Cancer Biology|February 1, 1991
MHC antigens in human melanomasD J Ruiter, V Mattijssen, E B Broecker, et al.
International Journal of Cancer|July 9, 1992
Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumorsV Mattijssen, L T Balemans, P A Steerenberg, et al.
American Journal of Perinatology|June 27, 1998
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case reportH L Claahsen, B A Semmekrot, P W van Dongen, et al.
Annals of Hematology|March 24, 1999
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphomaA H Mulder, J M Raemaekers, R H Boerman, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesV Mattijssen, A Schattenberg, N Schaap, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapyV Mattijssen, J Van Moorselaar, P H De Mulder, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesV Mattijssen, P H De Mulder, L Schalkwijk, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activityL T Balemans, V Mattijssen, P A Steerenberg, et al.
International Journal of Cancer|October 21, 1993
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcomeV Mattijssen, H M Peters, L Schalkwijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|February 1, 1991
MHC antigens in human melanomasD J Ruiter, V Mattijssen, E B Broecker, et al.
International Journal of Cancer|July 9, 1992
Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumorsV Mattijssen, L T Balemans, P A Steerenberg, et al.
American Journal of Perinatology|June 27, 1998
Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case reportH L Claahsen, B A Semmekrot, P W van Dongen, et al.
Annals of Hematology|March 24, 1999
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphomaA H Mulder, J M Raemaekers, R H Boerman, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesV Mattijssen, A Schattenberg, N Schaap, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapyV Mattijssen, J Van Moorselaar, P H De Mulder, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesV Mattijssen, P H De Mulder, L Schalkwijk, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activityL T Balemans, V Mattijssen, P A Steerenberg, et al.
International Journal of Cancer|October 21, 1993
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcomeV Mattijssen, H M Peters, L Schalkwijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 2